Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Herrmann

Showing results (191-200 of 343) with videos related to

Pageof 35
Sort By:
European Journal of Heart Failure|November 28, 2002
Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studiesStefan-Martin Herrmann, Viviane Nicaud, Klaus Schmidt-Petersen, et al.
Seminars in Immunopathology|November 8, 2019
Towards a pro-resolving concept in systemic lupus erythematosusSebastian Boeltz, Melanie Hagen, Jasmin Knopf, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 28, 2022
Neutrophil Extracellular Trap-Borne Elastase Prevents Inflammatory Relapse in Intercritical GoutLei Liu, Lizhen Shan, Han Wang, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 25, 2022
Evaluation of a rapid deployment prosthesis strategy for the treatment of aortic valve endocarditisSergey Belyaev, Florian Ernst Martin Herrmann, Alexey Dashkevich, et al.
Heart (British Cardiac Society)|October 4, 2024
New-onset atrial fibrillation after coronary surgery and stroke risk: a nationwide cohort studyAmar Taha, Andreas Martinsson, Susanne J Nielsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2012
Induction of type I IFN is a physiological immune reaction to apoptotic cell-derived membrane microparticlesMartin Schiller, Marijo Parcina, Petra Heyder, et al.
Modern Rheumatology|October 10, 2006
The low-throughput protein A adsorber: an immune modulatory device. Hypothesis for the mechanism of action in the treatment of rheumatoid arthritisJürgen Brunner, Peter M Kern, Udo S Gaipl, et al.
International Journal of Molecular Sciences|April 4, 2013
Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytesChristina Janko, Stephan Dürr, Luis E Munoz, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 4, 2010
Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other playersKristin Kruse, Christina Janko, Vilma Urbonaviciute, et al.
Cellular Microbiology|July 26, 2012
Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cellsPaola Quattroni, Yanwen Li, Davide Lucchesi, et al.
Pageof 35

Showing results (191-200 of 343) with videos related to

Sort By:
Pageof 35
European Journal of Heart Failure|November 28, 2002
Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studiesStefan-Martin Herrmann, Viviane Nicaud, Klaus Schmidt-Petersen, et al.
Seminars in Immunopathology|November 8, 2019
Towards a pro-resolving concept in systemic lupus erythematosusSebastian Boeltz, Melanie Hagen, Jasmin Knopf, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 28, 2022
Neutrophil Extracellular Trap-Borne Elastase Prevents Inflammatory Relapse in Intercritical GoutLei Liu, Lizhen Shan, Han Wang, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 25, 2022
Evaluation of a rapid deployment prosthesis strategy for the treatment of aortic valve endocarditisSergey Belyaev, Florian Ernst Martin Herrmann, Alexey Dashkevich, et al.
Heart (British Cardiac Society)|October 4, 2024
New-onset atrial fibrillation after coronary surgery and stroke risk: a nationwide cohort studyAmar Taha, Andreas Martinsson, Susanne J Nielsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2012
Induction of type I IFN is a physiological immune reaction to apoptotic cell-derived membrane microparticlesMartin Schiller, Marijo Parcina, Petra Heyder, et al.
Modern Rheumatology|October 10, 2006
The low-throughput protein A adsorber: an immune modulatory device. Hypothesis for the mechanism of action in the treatment of rheumatoid arthritisJürgen Brunner, Peter M Kern, Udo S Gaipl, et al.
International Journal of Molecular Sciences|April 4, 2013
Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytesChristina Janko, Stephan Dürr, Luis E Munoz, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 4, 2010
Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other playersKristin Kruse, Christina Janko, Vilma Urbonaviciute, et al.
Cellular Microbiology|July 26, 2012
Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cellsPaola Quattroni, Yanwen Li, Davide Lucchesi, et al.
Pageof 35